Molecular Precision is a research and technical consultancy focused on the structured design, representation and translation of complex biological systems.
Based in Northern Ireland and operated by Noviota Limited, our work sits at the intersection of biological engineering, nanomedicine, technical standards and regulatory science.
We develop methods, frameworks and technical approaches that make biological designs more explicit, traceable and reproducible.
Modern biological systems are rarely simple. A single engineered system may involve biological components, molecular interactions, material properties, delivery mechanisms, manufacturing constraints, experimental evidence and regulatory requirements.
Yet the information describing these systems is frequently fragmented across publications, datasets, diagrams, laboratory records, specifications and individual expertise. Molecular Precision works on the structures that connect them.
Our focus is not simply on documenting biological systems, but on representing the relationships between intent, requirements, architecture, specification and evidence.
This provides a clearer foundation for research, engineering, collaboration and translation.
We work with structured approaches to biological design, including the Synthetic Biology Open Language (SBOL3). Standards provide a way to represent biological systems consistently and computationally, improving interoperability, reproducibility, provenance and reuse.
Our work considers both the practical implementation of existing standards and the broader question of how increasingly complex biological designs should be represented.
Nanomedicine combines biology, materials science, drug delivery, engineering and manufacturing. Molecular Precision develops structured approaches for reasoning across these domains.
The Molecular Precision Nanomedicine Design Stack connects clinical and therapeutic intent with biological interaction, delivery architecture, nanomaterial architecture and manufacturing specification.
The objective is straightforward: every significant design characteristic should have a reason for being there.
Complex scientific systems eventually need to be communicated through specifications, evidence and technical documentation. We develop approaches for maintaining traceability between biological intent, engineering decisions, experimental evidence and technical requirements.
This helps preserve the reasoning behind a system as it moves from research towards development and translation.
Biology does not behave like conventional engineering. Biological systems are contextual, dynamic and uncertain. Experimental evidence changes. Mechanisms are revised. Designs evolve as understanding develops.
Structured biological design must accommodate that uncertainty rather than pretending it does not exist. Our approach therefore emphasises:
Molecular Precision operates across research and technical practice. Our research examines how biological systems can be represented, structured and engineered more rigorously. Our technical work applies those ideas to real biological design, nanomedicine and development problems.
The relationship between the two is deliberate. Practical problems identify where existing methods and standards are insufficient. Research provides the opportunity to develop better approaches. Those approaches can then be tested through practical application.
This cycle of research, implementation and refinement underpins the development of Molecular Precision frameworks and methodologies.
Explore Research →Molecular Precision is based in Northern Ireland and works with research, biotechnology and technical communities without geographic restriction.
Northern Ireland provides a particularly relevant environment for interdisciplinary work spanning life sciences, engineering, research and technology.
Our work is designed to contribute to wider international scientific and technical communities through research, standards, collaboration and open scholarly discussion.
Molecular Precision is operated by Noviota Limited, a Northern Ireland company developing research, technology and technical infrastructure across the biological sciences.
Within Noviota, Molecular Precision provides a focused environment for work on biological design standards, nanomedicine architecture and regulatory translation.
This relationship allows Molecular Precision to remain specialised while connecting its work to broader research and technology development.
Yes. Molecular Precision is operated by Noviota Limited, a Northern Ireland company (NI741562) developing research, technology and technical infrastructure across the biological sciences. Within Noviota, Molecular Precision provides a focused environment for work on biological design standards, nanomedicine architecture and regulatory translation.
Molecular Precision is based in Northern Ireland and works with research, biotechnology and technical communities internationally, without geographic restriction.
In part. Molecular Precision develops an open SBOL3 implementation of the Nanomedicine Design Stack, publicly available on GitHub, and shares research, working papers and analysis through its published work. Client engagements often involve confidential biological designs and are not published.
We work with research groups, biotechnology organisations and development teams addressing problems in biological design, nanomedicine and technical translation.
Engagements range from focused technical reviews and standards implementation to design frameworks, research collaborations and longer development programmes.